Synopsis
BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery.
The global BioMEMS and Microsystem in Healthcare market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of BioMEMS and Microsystem in Healthcare in various end use industries. The expanding demands from the Microfluidics, Micro Dispensers for Drug Delivery, Low Meters and Others, are propelling BioMEMS and Microsystem in Healthcare market. BioMEMS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microsystem segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BioMEMS and Microsystem in Healthcare, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BioMEMS and Microsystem in Healthcare market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BioMEMS and Microsystem in Healthcare market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BioMEMS and Microsystem in Healthcare sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BioMEMS and Microsystem in Healthcare covered in this report include Bluechiip, Cepheid, Given Imaging and Integrated Sensing, etc.
The global BioMEMS and Microsystem in Healthcare market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluechiip
Cepheid
Given Imaging
Integrated Sensing
Global BioMEMS and Microsystem in Healthcare market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BioMEMS and Microsystem in Healthcare market, Segment by Type:
BioMEMS
Microsystem
Global BioMEMS and Microsystem in Healthcare market, by Application
Microfluidics
Micro Dispensers for Drug Delivery
Low Meters
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of BioMEMS and Microsystem in Healthcare companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of BioMEMS and Microsystem in Healthcare
1.1 BioMEMS and Microsystem in Healthcare Market Overview
1.1.1 BioMEMS and Microsystem in Healthcare Product Scope
1.1.2 BioMEMS and Microsystem in Healthcare Market Status and Outlook
1.2 Global BioMEMS and Microsystem in Healthcare Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global BioMEMS and Microsystem in Healthcare Market Size by Region (2018-2029)
1.4 Global BioMEMS and Microsystem in Healthcare Historic Market Size by Region (2018-2023)
1.5 Global BioMEMS and Microsystem in Healthcare Market Size Forecast by Region (2024-2029)
1.6 Key Regions, BioMEMS and Microsystem in Healthcare Market Size (2018-2029)
1.6.1 North America BioMEMS and Microsystem in Healthcare Market Size (2018-2029)
1.6.2 Europe BioMEMS and Microsystem in Healthcare Market Size (2018-2029)
1.6.3 Asia-Pacific BioMEMS and Microsystem in Healthcare Market Size (2018-2029)
1.6.4 Latin America BioMEMS and Microsystem in Healthcare Market Size (2018-2029)
1.6.5 Middle East & Africa BioMEMS and Microsystem in Healthcare Market Size (2018-2029)
2 BioMEMS and Microsystem in Healthcare Market by Type
2.1 Introduction
2.1.1 BioMEMS
2.1.2 Microsystem
2.2 Global BioMEMS and Microsystem in Healthcare Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global BioMEMS and Microsystem in Healthcare Historic Market Size by Type (2018-2023)
2.2.2 Global BioMEMS and Microsystem in Healthcare Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America BioMEMS and Microsystem in Healthcare Revenue Breakdown by Type (2018-2029)
2.3.2 Europe BioMEMS and Microsystem in Healthcare Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific BioMEMS and Microsystem in Healthcare Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America BioMEMS and Microsystem in Healthcare Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa BioMEMS and Microsystem in Healthcare Revenue Breakdown by Type (2018-2029)
3 BioMEMS and Microsystem in Healthcare Market Overview by Application
3.1 Introduction
3.1.1 Microfluidics
3.1.2 Micro Dispensers for Drug Delivery
3.1.3 Low Meters
3.1.4 Others
3.2 Global BioMEMS and Microsystem in Healthcare Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global BioMEMS and Microsystem in Healthcare Historic Market Size by Application (2018-2023)
3.2.2 Global BioMEMS and Microsystem in Healthcare Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America BioMEMS and Microsystem in Healthcare Revenue Breakdown by Application (2018-2029)
3.3.2 Europe BioMEMS and Microsystem in Healthcare Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific BioMEMS and Microsystem in Healthcare Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America BioMEMS and Microsystem in Healthcare Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa BioMEMS and Microsystem in Healthcare Revenue Breakdown by Application (2018-2029)
4 BioMEMS and Microsystem in Healthcare Competition Analysis by Players
4.1 Global BioMEMS and Microsystem in Healthcare Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BioMEMS and Microsystem in Healthcare as of 2022)
4.3 Date of Key Players Enter into BioMEMS and Microsystem in Healthcare Market
4.4 Global Top Players BioMEMS and Microsystem in Healthcare Headquarters and Area Served
4.5 Key Players BioMEMS and Microsystem in Healthcare Product Solution and Service
4.6 Competitive Status
4.6.1 BioMEMS and Microsystem in Healthcare Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bluechiip
5.1.1 Bluechiip Profile
5.1.2 Bluechiip Main Business
5.1.3 Bluechiip BioMEMS and Microsystem in Healthcare Products, Services and Solutions
5.1.4 Bluechiip BioMEMS and Microsystem in Healthcare Revenue (US$ Million) & (2018-2023)
5.1.5 Bluechiip Recent Developments
5.2 Cepheid
5.2.1 Cepheid Profile
5.2.2 Cepheid Main Business
5.2.3 Cepheid BioMEMS and Microsystem in Healthcare Products, Services and Solutions
5.2.4 Cepheid BioMEMS and Microsystem in Healthcare Revenue (US$ Million) & (2018-2023)
5.2.5 Cepheid Recent Developments
5.3 Given Imaging
5.3.1 Given Imaging Profile
5.3.2 Given Imaging Main Business
5.3.3 Given Imaging BioMEMS and Microsystem in Healthcare Products, Services and Solutions
5.3.4 Given Imaging BioMEMS and Microsystem in Healthcare Revenue (US$ Million) & (2018-2023)
5.3.5 Integrated Sensing Recent Developments
5.4 Integrated Sensing
5.4.1 Integrated Sensing Profile
5.4.2 Integrated Sensing Main Business
5.4.3 Integrated Sensing BioMEMS and Microsystem in Healthcare Products, Services and Solutions
5.4.4 Integrated Sensing BioMEMS and Microsystem in Healthcare Revenue (US$ Million) & (2018-2023)
5.4.5 Integrated Sensing Recent Developments
6 North America
6.1 North America BioMEMS and Microsystem in Healthcare Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe BioMEMS and Microsystem in Healthcare Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific BioMEMS and Microsystem in Healthcare Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America BioMEMS and Microsystem in Healthcare Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa BioMEMS and Microsystem in Healthcare Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 BioMEMS and Microsystem in Healthcare Market Dynamics
11.1 BioMEMS and Microsystem in Healthcare Industry Trends
11.2 BioMEMS and Microsystem in Healthcare Market Drivers
11.3 BioMEMS and Microsystem in Healthcare Market Challenges
11.4 BioMEMS and Microsystem in Healthcare Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List